Hypothesis: is accumulation of a furan dicarboxylic acid (3-carboxy-4- methyl-5-propyl-2-furanpropanoic acid) related to the neurological abnormalities in patients with renal failure?
The Plasma concentrations of a lipophilic furan dicarboxylic acid (3- carboxy-4-methyl-5-propyl-2-fluranpropanoic acid; 5-propyl FPA), which is highly bound to albumin and not removed by haemodialysis, have been measured in patients with renal impairment who were not dialysis dependent or who were t...
Κύριοι συγγραφείς: | Costigan, MG, Callaghan, C, Lindup, W |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
1996
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Relationship of plasma 3‐carboxy‐4‐methyl‐5‐propyl‐2‐furanpropanoic acid concentration with OATP1B activity in patients with chronic kidney disease
ανά: Hiroyuki Ono, κ.ά.
Έκδοση: (2024-02-01) -
Circulating 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) levels are associated with hyperglycemia and β cell dysfunction in a Chinese population
ανά: Shan Zhang, κ.ά.
Έκδοση: (2017-06-01) -
3-Carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) induces cell death through ferroptosis and acts as a trigger of apoptosis in kidney cells
ανά: Jung Sun Park, κ.ά.
Έκδοση: (2023-02-01) -
Direct synthesis of furan-2,5-dicarboxylic acid monoamides
ανά: Róbert Fischer, κ.ά.
Έκδοση: (2015-09-01) -
Process Analysis of Furan Dicarboxylic Acid Production from Lignocellulose Biomass
ανά: Dang Saebea, κ.ά.
Έκδοση: (2024-07-01)